AlloVir, Inc. (ALVR)

AlloVir Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	90.97	106.94	202.51	122.66	61.08
Short-Term Investments	93.82	127.7	46.46	233.66	64.99
Cash & Cash Equivalents	184.8	234.65	248.97	356.32	126.08
Cash Growth	-21.25%	-5.75%	-30.13%	182.62%	405.12%
Receivables	0	0	0	0	0.3
Other Current Assets	2.84	8.41	4.38	4.99	0.94
Total Current Assets	187.64	243.05	253.35	361.32	127.31
Property, Plant & Equipment	2.19	32.56	31.29	9.5	12.11
Other Long-Term Assets	0.97	1.46	1.95	0	0
Total Long-Term Assets	3.16	34.03	33.25	9.5	12.11
Total Assets	190.8	277.08	286.59	370.82	139.42
Accounts Payable	7.5	3.06	10.1	1.54	0.88
Current Debt	10.78	7.17	6.59	3.23	3.07
Other Current Liabilities	10.09	14.11	21.16	7.53	5.16
Total Current Liabilities	28.37	24.34	37.85	12.29	9.11
Long-Term Debt	16.65	28.22	23.48	5.46	8.69
Total Long-Term Liabilities	16.65	28.22	23.48	5.46	8.69
Total Liabilities	45.02	52.56	61.33	17.76	17.8
Total Debt	27.43	35.39	30.07	8.69	11.76
Debt Growth	-22.49%	17.70%	245.90%	-26.08%	-
Retained Earnings	-656.19	-465.78	-297.07	-125.1	-55.32
Comprehensive Income	-0.06	-0.47	-0.16	-0.11	0.07
Shareholders' Equity	145.78	224.52	225.27	353.06	-51.5
Net Cash / Debt	157.37	199.26	218.91	347.63	114.32
Net Cash / Debt Growth	-21.02%	-8.97%	-37.03%	204.09%	358.00%
Net Cash Per Share	1.51	2.60	3.49	12.92	88.90
Working Capital	159.27	218.71	215.5	349.02	118.21
Book Value Per Share	1.40	2.93	3.59	13.13	-40.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).